🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07438639
Enrolling by invitation Not applicable

Virtual Reality-supported Language Intervention for Preschool Children With DLD

NCT07438639 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2023-02-01
Last updated
2026-02-27

Condition(s) studied

Language Development Disorders

Investigational drug(s) / intervention(s)

Virtual Reality Rehabilitation System (VRRS)Taditional Speech Therapy

Virtual Reality Rehabilitation System (VRRS): The VRRS delivers personalized language therapy exercises via touchscreen interface. Activities target receptive language, repetition, naming, and spontaneous language production. All sessions are conducted by trained speech-language pathologists in accordance with standardized therapeutic protocols.

Taditional Speech Therapy: Standard speech-language therapy delivered in-person by certified therapists, targeting the same language domains with paper-based and interactive materials.

Study summary

This study aims to test the effectiveness of virtual reality-supported speech therapy in improving basic language skills in children aged 3 to 6 years diagnosed with Developmental Language Disorder (DLD). Participants are randomly assigned to either traditional speech therapy or virtual reality-supported therapy, with the same frequency and duration of intervention. Language outcomes are assessed before and after treatment using the Language development level test (TVL), a standardized assessment of Italian for preschoolers. The study adopts a randomized controlled design with individualized, goal-oriented therapy delivered by certified speech-language pathologists.

Eligibility

Sex
ALL
Min age
3 Years
Max age
8 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 3 and 6 years at enrollment * Clinical diagnosis of Developmental Language Disorder (DLD) based on DSM-5 and standardized language assessments * Developmental Quotient (DQ) \> 70 on the Griffiths III Scales * Good general health without neurological or psychiatric comorbidities * Informed consent signed by a parent or legal guardian Exclusion Criteria: * Age not between 3 and 6 years * Lack of clinical diagnosis of Developmental Language Disorder (DLD) * Developmental Quotient (DQ) \< 70 on the Griffiths Scale III * Presence of neurological or psychiatric comorbidities * Lack of signed informed consent from a parent or legal guardian

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Francesca Cucinotta Messina Italy

More IRCCS Centro Neurolesi Bonino Pulejo trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07438639 on ClinicalTrials.gov ↗ ← All trials in Italy